Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
25 July 2013Website:
http://www.histogen.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
regular market | Mon, 18 Nov 2024 14:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
What type of business is Histogen?
Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases. Histogen Inc. was founded in 2007 and is based in San Diego, California. On April 18, 2024, Histogen Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of California.
What sector is Histogen in?
Histogen is in the Healthcare sector
What industry is Histogen in?
Histogen is in the Biotechnology industry
What country is Histogen from?
Histogen is headquartered in United States
When did Histogen go public?
Histogen initial public offering (IPO) was on 25 July 2013
What is Histogen website?
https://www.histogen.com
Is Histogen in the S&P 500?
No, Histogen is not included in the S&P 500 index
Is Histogen in the NASDAQ 100?
No, Histogen is not included in the NASDAQ 100 index
Is Histogen in the Dow Jones?
No, Histogen is not included in the Dow Jones index
When was Histogen the previous earnings report?
No data
When does Histogen earnings report?
Next earnings report date is not announced yet